Build an Integrated Innovative Drug Production Platform
InnoCare Guangzhou has developed a full range of innovative drug manufacturing capabilities, from ASD to formulations, and has received approval for the commercial production of orelabrutinib.
Overcome the R&D Challenges of Innovative Drug Formulations
InnoCare Guangzhou has built a cutting-edge technology platform equipped with world-class solid dispersion and solid formulation production lines which incorporate spray drying and hot-melt extrusion, as well as three technology platforms – insoluble drug solubilization formulation, oral solid modified-release formulation, and targeted drug delivery formulation – to overcome the dissolution challenges of insoluble drugs.
Adhere to High-quality Development
InnoCare Guangzhou is dedicated to achieving world-class quality through state-of-the-art production processes and equipment, and has established a quality management system in line with the GMP standards of China, the US, the EU, and Japan.
AWARDS & HONORS
Guangzhou InnoCare was certified as a high-tech enterprise
Guangzhou InnoCare was certified as an SRDI SME
Guangzhou InnoCare was certified as the Solubilization Preparation Technology R&D Center in Guangdong
Guangzhou InnoCare was certified as a technologically advanced service enterprise
Guangzhou InnoCare was listed in Guangzhou's Top 100 Cutting-edge Enterprises